Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2023-02-09 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically marked as a '정정신고' (Correction Report). It details changes to previously granted stock options, including the number of shares and the list of recipients. This type of filing, which concerns changes to capital structure or equity-based compensation instruments, is classified under 'Share Issue/Capital Change' (SHA) in the provided schema, as it relates to the issuance or modification of equity-linked instruments.
2023-02-09 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of recipients and the number of shares granted due to cancellations. In the context of financial filings, announcements regarding stock options, share issuance, or capital changes are classified under 'Share Issue/Capital Change' (SHA).
2023-02-09 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically marked as a '정정신고' (Correction Report). It details changes to previously reported stock option grants, including adjustments to the number of recipients and the number of shares granted due to cancellations. This type of filing, which concerns changes to capital structure and equity-based compensation, falls under the category of share issues or capital changes in a regulatory context.
2023-02-09 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options). It details the issuance of stock options to employees, including the number of shares, exercise price, and legal basis under the company's articles of association. This type of disclosure regarding capital structure changes and employee compensation via stock options is classified as a share issue or capital change announcement.
2023-02-09 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Handok regarding the decision to pay cash dividends. It specifies the dividend amount per share, the dividend yield, the total dividend amount, the record date, and the date of the upcoming general meeting of shareholders. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2023-02-09 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Handok) announcing a change in financial structure (revenue/profit) exceeding 30%. This is a standard preliminary earnings disclosure required by the Korea Exchange (KRX) before the final audited annual report is filed. Since it provides key financial highlights and is an initial announcement of results rather than the full annual report or a conference call transcript, it falls under the 'Earnings Release' category. FY 2022
2023-02-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.